Advertisement
Review Article| Volume 29, ISSUE 3, P607-622, August 2011

Heavy Metal Chelation in Neurotoxic Exposures

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Neurologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Duffus J.H.
        “Heavy metals” a meaningless term? (IUPAC Technical Report).
        Pure Appl Chem. 2002; 74: 793-807
        • Gaslin M.T.
        • Rubin C.
        • Pribitkin E.A.
        Silver nasal sprays: misleading Internet marketing.
        Ear Nose Throat J. 2008; 87: 217-220
        • Hori K.
        • Martin T.G.
        • Rainey P.
        • et al.
        Believe it or not silver still poisons!.
        Vet Hum Toxicol. 2002; 44: 291-292
        • Griffin J.P.
        Famous names: the Esing Bakery, Hong Kong.
        Adverse Drug React Toxicol Rev. 1997; 16: 79-81
        • Meggs W.J.
        • Hoffman R.S.
        • Shih R.D.
        • et al.
        Thallium poisoning from maliciously contaminated food.
        J Toxicol Clin Toxicol. 1994; 32: 723-730
        • Desenclos J.C.
        • Wilder M.H.
        • Coppenger G.W.
        • et al.
        Thallium poisoning: an outbreak in Florida, 1988.
        South Med J. 1992; 85: 1203-1206
        • Powell P.P.
        Minamata disease: a story of mercury’s malevolence.
        South Med J. 1991; 84: 1352-1358
        • Ahsan H.
        • Chen Y.
        • Parvez F.
        • et al.
        Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the health effects of arsenic longitudinal study.
        Am J Epidemiol. 2006; 163: 1138-1148
        • Patwardhan J.R.
        • Finckh E.S.
        Fatal cadmium-fume pneumonitis.
        Med J Aust. 1976; 1: 962-966
        • Clarkson T.W.
        • Magos L.
        • Myers G.J.
        The toxicology of mercury–current exposures and clinical manifestations.
        N Engl J Med. 2003; 349: 1731-1737
        • Schultz S.T.
        Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature.
        Acta Neurobiol Exp (Wars). 2010; 70: 187-195
        • Poland G.A.
        • Spier R.
        Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health.
        Vaccine. 2010; 28: 2361-2362
        • Schaffer A.W.
        • Pilger A.
        • Engelhardt C.
        • et al.
        Increased blood cobalt and chromium after total hip replacement.
        J Toxicol Clin Toxicol. 1999; 37: 839-844
        • Steens W.
        • von Foerster G.
        • Katzer A.
        Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-a case report.
        Acta Orthop. 2006; 77: 830-832
        • Jacobs J.J.
        • Skipor A.K.
        • Patterson L.M.
        • et al.
        Metal release in patients who have had a primary total hip arthroplasty. A prospective controlled, longitudinal study.
        J Bone Joint Surg Am. 1998; 80: 1447-1448
        • Savory J.
        • Sedor F.A.
        Arsenic poisoning.
        in: Brown S.S. Clinical chemistry and chemical toxicology of metals. Elsevier/North-Holland, New York1977: 271-286
        • Krachler M.
        • Zheng J.
        • Emons H.
        Speciation of antimony for the 21st century: promises and pitfalls.
        Trends Anal Chem. 2001; 20: 79-90
        • Lidsky T.I.
        • Schneider J.S.
        Lead neurotoxicity in children: basic mechanisms and clinical correlates.
        Brain. 2003; 126: 5-19
        • Regan C.M.
        Neural cell adhesion molecules, neuronal development and lead toxicity.
        Neurotoxicology. 1993; 14: 69-74
        • Melnick R.L.
        • Monti L.G.
        • Motzkin S.M.
        Uncoupling of mitochondrial oxidative phosphorylation by thallium.
        Biochem Biophys Res Commun. 1976; 69: 68-73
        • Mullins L.J.
        • Moore R.D.
        The movement of thallium ions in muscle.
        J Gen Physiol. 1960; 43: 759-773
        • Ibrahim D.
        • Froberg B.
        • Wolf A.
        • et al.
        Heavy metal poisoning: clinical presentations and pathophysiology.
        Clin Lab Med. 2006; 26: 67-97
        • Josephs K.A.
        • Ahlskog J.E.
        • Klos K.J.
        • et al.
        Neurologic manifestations in welders with pallidal MRI T1 hyperintensity.
        Neurology. 2005; 64: 2033-2039
        • Stepens A.
        • Logina I.
        • Liguts V.
        • et al.
        A parkinsonian syndrome in methcathinone users and the role of manganese.
        N Engl J Med. 2008; 358: 1009-1017
        • Short A.I.
        • Winney R.J.
        • Robson J.S.
        Reversible microcytic hypochromic anaemia in dialysis patients due to aluminum intoxication.
        Proc Eur Dial Transplant Assoc. 1980; 17: 226-233
        • Smith E.C.
        • Mahurkar S.D.
        • Mamdani B.H.
        • et al.
        Diagnosing dialysis dementia.
        Dial Transplant. 1978; 7: 1264-1274
        • Mendelowitz P.C.
        • Hoffman R.S.
        • Weber S.
        Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
        Ann Intern Med. 1990; 112: 140-141
        • Monseu G.
        • Struelens M.
        • Roland M.
        Bismuth encephalopathy.
        Acta Neurol Belg. 1976; 76: 301-308
        • Heyman A.
        • Pfeiffer J.B.
        • Willett R.W.
        Peripheral neuropathy caused by arsenical intoxication: a study of 41 cases with observations on the effects of BAL (2,3-dimercaptopropanol).
        N Engl J Med. 1956; 254: 401-409
        • Chuttani P.N.
        • Chawla L.S.
        • Sharma T.D.
        Arsenical neuropathy.
        Neurology. 1967; 17: 269-274
        • Bank W.J.
        • Pleasure D.E.
        • Suzuki K.
        • et al.
        Thallium poisoning.
        Arch Neurol. 1972; 26: 456-464
        • Arbouine M.W.
        • Wilson H.K.
        The effect of seafood consumption on the assessment of occupational exposure to arsenic by urinary arsenic speciation measurements.
        J Trace Elem Electrolytes Health Dis. 1992; 6: 153-160
        • Brown M.J.
        • Willis T.
        • Omalu B.
        • et al.
        Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005.
        Pediatrics. 2006; 118: e534-e536
        • Nagaraj M.V.
        • Rao P.V.
        • Susarala S.
        Copper sulphate poisoning, hemolysis and methaemoglobinemia.
        J Assoc Physicians India. 1985; 33: 308-309
        • Barbey J.T.
        • Pezzullo J.C.
        • Soignet S.L.
        Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
        J Clin Oncol. 2003; 21: 3609-3615
        • Beckman K.J.
        • Bauman J.L.
        • Pimental P.A.
        • et al.
        Arsenic-induced torsade de pointes.
        Crit Care Med. 1991; 19: 290-292
        • Ortega-Carnicer J.
        • Alcázar R.
        • De la Torre M.
        • et al.
        Pentavalent antimonial-induced torsade de pointes.
        J Electrocardiol. 1997; 30: 143-145
        • Greenberg G.N.
        • Levine R.J.
        Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations.
        J Occup Med. 1989 Oct; 31: 832-838
        • Sata F.
        • Araki S.
        • Yokoyama K.
        • et al.
        Adjustment of creatinine-adjusted values in urine to urinary flow rate: a study of eleven heavy metals and organic substances.
        Int Arch Occup Environ Health. 1995; 68: 64-68
        • Wagner S.L.
        • Weswig P.
        Arsenic in blood and urine of forest workers as indices of exposure to cacodylic acid.
        Arch Environ Health. 1974; 28: 77-79
        • Kersjes M.P.
        • Maurer J.R.
        • Trestrail J.H.
        • et al.
        An analysis of arsenic exposures referred to the Blodgett Regional Poison Center.
        Vet Hum Toxicol. 1987; 29: 75-78
        • Barrett S.
        Commercial hair analysis. Science or scam?.
        JAMA. 1985; 254: 1041-1045
        • Cullen N.M.
        • Wolf L.R.
        • St Clair D.
        Pediatric arsenic ingestion.
        Am J Emerg Med. 1995; 13: 432-435
      1. Barnhart S, Rosenstock L. Cadmium chemical pneumonitis chest 1984;789–91.

        • Czerwinski A.W.
        • Ginn H.E.
        Bismuth nephrotoxicity.
        Am J Med. 1964; 37: 969-975
        • Reed D.
        • Crawley J.
        • Faro S.N.
        • et al.
        Thallotoxicosis. Acute manifestations and sequelae.
        JAMA. 1963; 183: 516-522
        • Goebel H.H.
        • Schmidt P.F.
        • Bohl J.
        • et al.
        Polyneuropathy due to acute arsenic intoxication: biopsy studies.
        J Neuropathol Exp Neurol. 1990; 49: 137-149
        • Le Quesne P.M.
        • McLeod J.G.
        Peripheral neuropathy following a single exposure to arsenic: clinical course in four patients with electrophysiological and histological studies.
        J Neurol Sci. 1977; 32: 437-451
        • Cersosimo M.G.
        • Koller W.
        The diagnosis of manganese-induced parkinsonism.
        Neurotoxicology. 2006; 27: 340-346
        • Arjona A.
        • Mata M.
        • Bonet M.
        Diagnosis of chronic manganese intoxication by magnetic resonance imaging.
        N Engl J Med. 1997; 336: 964-965
        • Needleman H.L.
        • Gunnoe C.
        • Leviton A.
        • et al.
        Deficits in psychological and classroom performance of children with elevated dentine lead levels.
        N Engl J Med. 1979; 300: 689-695
        • Young E.G.
        • Smith R.P.
        Arsenic content of hair and bone in acute and chronic arsenical poisoning: review of 2 cases examined posthumously from medico-legal aspect.
        Br Med J. 1942; 1: 251-253
        • Rosenman K.D.
        • Valciukas J.A.
        • Glickman L.
        • et al.
        Sensitive indicators of inorganic mercury toxicity.
        Arch Environ Health. 1986; 41: 208-215
        • Whitaker J.A.
        • Austin W.
        • Nelson J.D.
        Edathamil calcium disodium (Versenate) diagnostic test for lead poisoning.
        Pediatrics. 1962; 29: 384-388
        • Weinberger H.L.
        • Post E.M.
        • Schneider T.
        • et al.
        An analysis of 248 initial mobilization tests performed on an ambulatory basis.
        Am J Dis Child. 1987; 141: 1266-1270
        • Markowitz M.E.
        • Rosen J.F.
        Need for the lead mobilization test in children with lead poisoning.
        J Pediatr. 1991; 119: 305-310
        • Saenger P.
        • Rosen J.F.
        • Markowitz M.
        Diagnostic significance of edetate disodium calcium testing in children with increased lead absorption.
        Am J Dis Child. 1982; 136: 312-315
        • Markowitz M.E.
        • Rosen J.F.
        Assessment of lead stores in children: validation of an 8-hour CaNa2EDTA provocative test.
        J Pediatr. 1984; 104: 337-341
        • Sokas R.K.
        • Atleson J.
        • Keogh J.P.
        Shortened forms of provocative lead chelation.
        J Occup Med. 1988; 30: 420-424
        • Haust H.L.
        • Ali H.
        • Haines D.S.
        • et al.
        Short-term administration of dimercaptopropanol (BAL) and calcium disodium edetate (EDTA) for diagnostic and therapeutic lead mobilization.
        Int J Biochem. 1980; 12: 897-904
        • Chisolm Jr., J.J.
        Mobilization of lead by calcium disodium edetate. A reappraisal.
        Am J Dis Child. 1987; 141: 1256-1257
        • Markowitz M.E.
        • Bijur P.E.
        • Ruff H.
        • et al.
        Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
        Pediatrics. 1993; 92: 265-271
        • Jugo S.
        • Maliković T.
        • Kostial K.
        Influence of chelating agents on the gastrointestinal absorption of lead.
        Toxicol Appl Pharmacol. 1975; 34: 259-263
        • Chia K.S.
        • Tan A.L.
        • Chia S.E.
        • et al.
        Renal tubular function of cadmium exposed workers.
        Ann Acad Med Singapore. 1992; 21: 756-759
        • Kales S.N.
        • Goldman R.H.
        Mercury exposure: current concepts, controversies, and a clinic’s experience.
        J Occup Environ Med. 2002; 44: 143-154
        • Allain P.
        • Mauras Y.
        • Premel-Cabic A.
        • et al.
        Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects.
        Br J Clin Pharmacol. 1991; 31: 347-349
        • Allain P.
        • Mauras Y.
        • Krari N.
        • et al.
        Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.
        Br J Clin Pharmacol. 1990; 29: 391-395
        • Allain P.
        • Mauras Y.
        • Chaleil D.
        • et al.
        Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
        Br J Clin Pharmacol. 1987; 24: 207-212
        • Perry Jr., H.M.
        • Perry E.F.
        Normal concentrations of some trace metals in human urine: changes produced by ethylenediaminetetraacetate.
        J Clin Invest. 1959; 38: 1452-1463
        • Frumkin H.
        • Manning C.C.
        • Williams P.L.
        • et al.
        Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure?.
        Environ Health Perspect. 2001; 109: 167-171
        • Soden S.E.
        • Lowry J.A.
        • Garrison C.B.
        • et al.
        24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study.
        Clin Toxicol (Phila). 2007; 45: 476-481
        • Brodkin E.
        • Copes R.
        • Mattman A.
        • et al.
        Lead and mercury exposures: interpretation and action.
        CMAJ. 2007; 176: 59-63
        • Risher J.F.
        • Amler S.N.
        Mercury exposure: evaluation and intervention. The inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning.
        Neurotoxicology. 2005; 26: 691-699
        • Charlton N.
        • Wallace K.L.
        American College of Medical Toxicology position statement on post-chelator challenge urinary metal testing.
        J Med Toxicol. 2010; 6: 74-75
        • Andersen A.H.
        Experimental studies on the pharmacology of activated charcoal. III: adsorption from gastro-intestinal contents.
        Acta Pharmacol Toxicol. 1948; 4: 275-284
        • Lehmann P.A.
        • Favari L.
        Parameters for the adsorption of thallium ions by activated charcoal and Prussian blue.
        J Toxicol Clin Toxicol. 1984; 22: 331-339
        • Hoffman R.S.
        • Stringer J.A.
        • Feinberg R.S.
        • et al.
        Comparative efficacy of thallium adsorption by activated charcoal, Prussian blue, and sodium polystyrene sulfonate.
        J Toxicol Clin Toxicol. 1999; 37: 833-837
        • Bailly R.
        • Lauwerys R.
        • Buchet J.P.
        • et al.
        Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony.
        Br J Ind Med. 1991; 48: 93-97
        • Basinger M.A.
        • Jones M.M.
        Structural requirements for chelate antidotal efficacy in acute antimony (III) intoxication.
        Res Commun Chem Pathol Pharmacol. 1981; 32: 355-363
        • Zimmer L.J.
        • Carter D.E.
        The efficacy of 2,3-dimercaptopropanol and d-penicillamine on methyl mercury induced neurological signs and weight loss.
        Life Sci. 1978; 23: 1025-1034
        • Thompson R.H.
        • Whittaker V.P.
        Antidotal activity of British anti-Lewisite against compounds of antimony, gold and mercury.
        Biochem J. 1947; 41: 342-346
        • Aposhian H.V.
        • Carter D.E.
        • Hoover T.D.
        • et al.
        DMSA, DMPS, and DMPA–as arsenic antidotes.
        Fundam Appl Toxicol. 1984; 4: S58-S70
        • Kreppel H.
        • Reichl F.X.
        • Kleine A.
        • et al.
        Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
        Fundam Appl Toxicol. 1995; 26: 239-245
        • Rogan W.J.
        • Dietrich K.N.
        • Ware J.H.
        • et al.
        The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
        N Engl J Med. 2001; 344: 1421-1426
        • Baxter A.J.
        • Krenzelok E.P.
        Pediatric fatality secondary to EDTA chelation.
        Clin Toxicol (Phila). 2008; 46: 1083-1084